Hubei Jumpcan Pharmaceutical Co., Ltd. is a high-risk Pharmaceuticals company based in China with an ESG score of 36.5. Specializing in research, development, manufacturing, and trading of Chinese traditional and western medicines, the company offers a wide range of products in various medical areas.